Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2024-10-21 Regulatory Filings
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - IVX 4 pages 14.8KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of certain securities (options) for Invion Limited, including the number of securities ceased, the reason (expiry of options), and the updated issued capital following these changes. The document is a formal announcement related to changes in the company's securities, specifically the cessation of certain options. It does not contain financial statements, management discussion, or detailed financial results. It is a regulatory announcement about securities cessation, which fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit into more specific categories like capital changes or share issues (which usually involve new shares or capital raising). The document length is 4150 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the best classification is Regulatory Filings (RNS).
2024-10-21 English
Change of Director's Interest Notice - Alistair Bennallack 2 pages 241.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in relevant interests in securities, including the disposal of unlisted options and the number of securities held before and after the change. The document is a formal notification of a director's personal share transactions. It does not contain financial statements, management discussion, or other report content. Therefore, it fits the definition of 'Director's Dealing' (DIRS). The document length is 3421 characters, consistent with a short notice rather than a full report.
2024-10-21 English
Securities Consolidation Clarification 2 pages 171.3KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement from Invion Limited dated 16 October 2024. It provides a clarification regarding the indicative timetable for a securities consolidation (a 100:1 consolidation of capital). The content is focused on the schedule and procedural details of the share consolidation event, including dates for trading, record dates, and register updates. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is relatively short (3749 characters) and serves as an announcement of a capital structure change event rather than a full report or detailed financial disclosure. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as consolidations.
2024-10-15 English
Notice of Annual General Meeting/Proxy Form 28 pages 1.5MB
AGM Information Classification · 100% confidence The document is a detailed notice of the Annual General Meeting (AGM) for Invion Limited, including the date, time, virtual meeting details, agenda items, resolutions to be voted on, proxy information, and explanatory statements. It explicitly states it is a "Notice of Annual General Meeting" and includes typical AGM content such as election of directors, adoption of remuneration report, ratification of share issues, appointment of auditor, and capital consolidation. There is no financial report or detailed financial data included, only the notice and explanatory materials for the meeting. The document is not a report itself but the official meeting notice and related materials for the AGM. Therefore, it fits the category AGM Information (AGM-R).
2024-10-14 English
Consolidation/Split - IVX 6 pages 22.9KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3A.3 - Notification of security consolidation or split' and contains detailed information about a security consolidation event for Invion Limited, including the consolidation ratio, record dates, trading dates, and the number of securities before and after consolidation. It is an announcement about a corporate action affecting the company's capital structure, specifically a security consolidation (reverse stock split). There are no financial statements, earnings data, or management discussion present. The document is not a report but an official announcement of a capital change event. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail confirm it is not a brief notice or a report publication announcement but a full announcement of the capital change event.
2024-10-14 English
Investor Presentation 25 pages 2.5MB
Investor Presentation Classification · 100% confidence The document is titled as an "Investor Presentation" and explicitly states it is a presentation to be used by the company's executives at investor meetings and seminars. It contains detailed information about the company's technology, clinical trials, and business highlights, typical of investor presentations. The document is lengthy (15,000 characters) and contains no indication that it is an announcement of a report or a certification. It is not a financial report, earnings release, or regulatory filing. Therefore, the document fits the category of an Investor Presentation (IP).
2024-09-18 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.